Hepatic Encephalopathy

TL;DR. Hepatic encephalopathy is a serious neurological condition where a damaged or abnormal liver fails to filter toxins from the bloodstream, leading to brain dysfunction, disorientation, and behavioral changes.

Lethargy and depression are among the most common early signs of hepatic encephalopathy in dogs.

What is it?

Hepatic encephalopathy (HE) is a complex metabolic syndrome that directly impacts the central nervous system. Under normal conditions, your pet's liver acts as a highly efficient filtration system. When your dog or cat digests food, bacteria in the intestines break down proteins, producing various byproducts. The most prominent of these byproducts is ammonia, a highly toxic compound. In a healthy animal, blood carrying these toxins travels from the intestines directly to the liver via the portal vein. The liver then extracts these toxins, detoxifies them, and converts them into harmless substances like urea, which are safely excreted in the urine.

When an animal develops hepatic encephalopathy, this vital filtration process breaks down. This failure typically occurs due to moderate to severe liver disease, liver insufficiency, or abnormal blood vessels known as portosystemic shunts. Because the liver cannot perform its detoxifying duties, gut-derived neurotoxins—primarily ammonia—bypass hepatic clearance entirely. These toxins enter the systemic bloodstream, circulate throughout the body, and cross the blood-brain barrier. Once inside the brain, they disrupt normal neurotransmitter function, cause swelling of brain cells, and lead to progressive central nervous system dysfunction.

Understanding this condition is critical for pet owners because the symptoms can be incredibly distressing and, if left untreated, life-threatening. Because the brain is highly sensitive to these circulating toxins, even minor fluctuations in liver function or diet can trigger sudden, severe neurological crises.

Causes & risk factors

The underlying causes of hepatic encephalopathy in dogs and cats generally fall into two categories: structural vascular abnormalities and primary liver failure. By far, the most common cause identified in young veterinary patients is a congenital portosystemic shunt (PSS).

"In dogs and cats, congenital extrahepatic or intrahepatic portal-tosystemic venous communications are the most frequent cause of HE; up to 95% of affected animals demonstrate neurologic clinical signs."
— Small Animal Critical Care Medicine, p. 511

These portosystemic shunts are abnormal blood vessels that act as a "bypass lane," routing blood from the digestive tract directly into the main circulatory system before the liver has a chance to filter it. These shunts are typically a single congenital vessel, although multiple extrahepatic or intrahepatic shunts can occasionally occur. Another vascular cause includes hepatic arteriovenous malformations, which also disrupt normal blood flow through the liver.

In older pets, hepatic encephalopathy is more commonly associated with acquired, chronic liver diseases that lead to liver failure or cirrhosis. When liver tissue becomes severely scarred or diseased, it loses the functional capacity to process toxins.

Furthermore, several secondary factors can lower your pet's threshold for developing hepatic encephalopathy or trigger an acute crisis. For instance, concurrent inflammatory diseases can release inflammatory proteins called cytokines into the bloodstream, which worsens brain swelling and makes the brain more sensitive to ammonia. This explains why two pets with the exact same blood ammonia levels might show vastly different levels of neurological impairment. Other common triggers include high-protein meals, constipation (which increases toxin production in the gut), gastrointestinal bleeding, and certain medications.

Signs to watch for

The clinical signs of hepatic encephalopathy can be highly variable, fluctuating in severity throughout the day. They often worsen shortly after a meal when protein digestion produces a surge of ammonia.

Common Signs

• Lethargy and depression: Your pet may seem unusually tired, sluggish, or unresponsive to their surroundings.
• Disorientation and personality changes: Pets may wander aimlessly, get stuck in corners, or fail to recognize familiar family members.
• Pacing and circling: Continuous, repetitive walking or walking in circles is a classic sign of neurological distress.
• Head pressing: Your pet may firmly press their head against walls, furniture, or the floor. This is a major red flag indicating increased pressure or irritation in the brain.
• Star gazing: Your pet may stand still and stare blankly up at the ceiling or into space.
• Central (amaurotic) blindness: Your pet may appear suddenly blind, bumping into objects, even though their eyes look completely normal and their pupils may still react to light.
• Ptyalism (excessive drooling): This is particularly common in cats suffering from hepatic encephalopathy.
• Polyuria and polydipsia: Increased urination and increased thirst are frequently observed, especially in pets with underlying portosystemic shunts.

Occasional Signs

• Anorexia and vomiting: A loss of appetite and gastrointestinal upset can occur as liver function declines.
• Ataxia: A wobbly, uncoordinated, "drunken" gait.
• Stupor: A state of near-unconsciousness where the pet is highly unresponsive to external stimuli.
• Seizures: Sudden, uncontrolled electrical activity in the brain, which is a severe neurological emergency.
• Stranguria and hematuria: Straining to urinate or blood in the urine can occur, often because pets with shunts are prone to developing ammonium urate bladder stones.

Rare Signs

• Coma: Complete loss of consciousness, representing a terminal or near-terminal state of brain swelling.

Head pressing is a critical neurological warning sign that requires immediate veterinary attention.

How vets diagnose it

Diagnosing hepatic encephalopathy requires a systematic approach. Because the neurological signs of this condition are not specific to the liver, your vet must rule out other potential causes, such as primary brain diseases, toxins, or other metabolic disorders.

"The diagnosis of HE is made when an animal has clinical signs compatible with the condition, and alterations on a biochemical panel and liver function tests confirming moderate to severe liver disease... At the same time, none of the clinical signs described are specific for HE and other potential diagnoses, including other metabolic disorders, toxin o"
— Small Animal Critical Care Medicine, p. 512

Your vet will begin with a comprehensive physical and neurological exam, followed by a suite of diagnostic tests:

• Biochemical Panel: This routine blood test evaluates overall organ health. In pets with liver disease or shunts, it may reveal low blood urea nitrogen (BUN), low albumin, low cholesterol, and mild to moderate elevations in liver enzymes.
• Pre- and Postprandial Bile Acids: This is a highly sensitive test of liver function. Your vet will draw a baseline blood sample after a period of fasting, feed your pet a high-fat meal to stimulate gallbladder contraction, and draw a second sample two hours later. Significantly elevated bile acids confirm that the liver is not functioning or filtering blood properly.
• Blood Ammonia Levels: Measuring the concentration of ammonia in the blood can provide direct evidence of the toxin responsible for hepatic encephalopathy. However, this test is highly sensitive to handling and must be run immediately on specialized equipment.
• Ammonia Tolerance Test: If resting ammonia levels are normal but a shunt is still suspected, this test may be performed by administering a controlled dose of ammonia and measuring how efficiently the liver clears it.
• Sulfobromophthalein (BSP) Dye Retention Test: This is an older, specialized liver function test that measures how quickly the liver can clear a specific dye from the bloodstream.
• Rectal Portal Scintigraphy: This advanced, non-invasive nuclear imaging study involves administering a radioactive marker into the rectum. In a healthy pet, the marker travels directly to the liver. In a pet with a shunt, the marker bypasses the liver and is detected in the heart first, confirming an abnormal vascular bypass.
• Liver Histopathology: Obtaining a tissue biopsy of the liver allows pathologists to examine the cellular structure under a microscope. This is the gold standard for identifying the exact type of liver disease, such as cirrhosis, microvascular dysplasia, or hepatitis.

Diagnostic imaging, such as ultrasound or scintigraphy, helps veterinarians identify abnormal blood vessels bypassing the liver.

Treatment options

The treatment of hepatic encephalopathy is divided into two phases: stabilizing an acute, life-threatening neurological crisis, and long-term medical or surgical maintenance.

Acute Crisis Management

An acute encephalopathic crisis is a medical emergency that requires immediate, intensive veterinary hospitalization.

• Ammonia Reduction and Laxatives: Lactulose is a disaccharide laxative and the cornerstone of therapy. It works in the colon to create an acidic environment, which converts toxic ammonia (NH3) into ammonium (NH4+). Ammonium cannot cross the intestinal wall into the bloodstream and is safely trapped in the gut. Lactulose also acts as an osmotic laxative, speeding up transit time to expel these toxins before they can be absorbed.
• Anticonvulsants and Anesthetics: If your pet is experiencing seizures, your vet may administer injectable anesthetics like Propofol to rapidly control brain activity. Anticonvulsants like Levetiracetam may also be utilized to manage seizure activity.
• Osmotic Diuretics: If severe brain swelling (cerebral edema) is suspected, your vet may administer Mannitol, an osmotic diuretic that helps draw excess fluid out of brain tissues and into the bloodstream to be excreted.
• Medications to Avoid: Central nervous system depressants, such as Barbiturates and Diazepam, must be avoided or used with extreme caution. Because a failing liver cannot metabolize these drugs normally, they can cause profound, prolonged sedation and worsen neurological depression.

Long-Term Medical Management

For pets that cannot undergo surgery, or those being stabilized prior to surgery, long-term medical therapy focuses on reducing toxin production in the gut.

• Antibiotic Therapy: Specific antibiotics are prescribed to reduce the population of ammonia-producing bacteria in the intestines. These include Metronidazole (an antibiotic and antiprotozoal), Ampicillin (an aminopenicillin), and Neomycin (an aminoglycoside antibiotic).
• Dietary Modification: Feeding a highly digestible, moderate-protein diet (often utilizing high-quality dairy or soy proteins rather than meat) helps minimize the production of nitrogenous wastes in the intestines.

Surgical Correction

For pets diagnosed with a congenital portosystemic shunt, surgery is the treatment of choice. A surgeon will place a device (such as an ameroid constrictor) around the abnormal vessel. This device slowly closes the shunt over several weeks, allowing the liver to gradually adapt to increased blood flow without causing sudden, dangerous high blood pressure in the portal system (portal hypertension).

Prognosis

The long-term outlook for pets with hepatic encephalopathy depends heavily on the underlying cause and whether surgical correction is possible.

For dogs with congenital portosystemic shunts, surgical correction often permanently resolves clinical signs, allowing them to live normal, healthy lives.

For pets managed medically, the prognosis is highly variable. Some animals can achieve complete recovery and successful long-term control, especially if their acute crises are triggered by a definable, manageable event.

"The treatment of acute encephalopathic crises... is worthwhile because some animals can go on to complete recovery and successful long-term medical management, particularly if the acute crisis was triggered by a definable event (e. g. , acute GI bleeding in a dog with chronic liver disease and portal hypertension)."
— Internal Medicine, p. 625

However, if the underlying cause is progressive, end-stage liver failure (cirrhosis), medical management is palliative, aimed at maintaining quality of life for as long as possible.

Prevention

Because congenital portosystemic shunts are genetic developmental defects, they cannot be prevented. However, responsible breeding practices—including screening parent dogs of predisposed breeds—can help reduce the incidence of these vascular anomalies.

For pets with known liver disease, preventing acute encephalopathic crises involves strict adherence to prescribed diets, avoiding high-protein treats, and monitoring closely for signs of gastrointestinal bleeding or infection, which can trigger a sudden neurological decline.

When to call your vet

Hepatic encephalopathy can progress rapidly from mild lethargy to life-threatening seizures or coma. You must seek emergency veterinary care immediately if your pet exhibits any of the following signs:

• Seizures or severe muscle tremors
• Extreme disorientation, pacing, or inability to stand
• Continuous head pressing against walls or furniture
• Sudden apparent blindness
• Stupor, extreme unresponsiveness, or loss of consciousness (coma)

If your pet has been diagnosed with liver disease and you notice subtle changes, such as a sudden loss of appetite, mild drooling, or increased lethargy, contact your veterinarian promptly to adjust their medical management before a crisis develops.

For specific breeds

Several breeds of dogs and cats have a documented predisposition to congenital portosystemic shunts or underlying liver conditions that can lead to hepatic encephalopathy.

Predisposed Dog Breeds:

• Yorkshire Terrier
• Cairn Terrier
• Miniature Schnauzer
• Miniature Poodle
• Chinese Shar-Pei

Predisposed Cat Breeds:

• Siamese Cat
• Abyssinian
• Oriental Longhair

If you own one of these breeds, pay close attention to any subtle behavioral changes, slow growth, or prolonged recovery from anesthesia, as these can be early indicators of an underlying liver shunt.

Sources

• Small Animal Critical Care Medicine, 2nd Edition, pages 511–512.
• Internal Medicine, 5th Edition, pages 543, 625.

My highlights & notes

New note